Clinical Trial Update: Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 trial evaluating the combination of BMS-754807 with Erbitux (cetuximab) in advanced or metastatic colorectal cancer and head and neck can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer

Drugs mentioned

• BMS-754807 (BMS-754807)
• ERBITUX (cetuximab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Colorectal Cancer, Head and Neck Cancer | Phase 1, Phase 2 | Status: TERMINATED